Literature DB >> 11417495

Refinement of vaccine potency testing with the use of humane endpoints.

C F Hendriksen, B Steen.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11417495     DOI: 10.1093/ilar.41.2.105

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


× No keyword cloud information.
  5 in total

Review 1.  Critical evaluation of challenges and future use of animals in experimentation for biomedical research.

Authors:  Vijay Pal Singh; Kunal Pratap; Juhi Sinha; Koundinya Desiraju; Devika Bahal; Ritushree Kukreti
Journal:  Int J Immunopathol Pharmacol       Date:  2016-09-30       Impact factor: 3.219

2.  Association of Primate Veterinarians' Humane Endpoint Guidelines for Nonhuman Primates in Biomedical Research.

Authors: 
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-01-01       Impact factor: 1.232

3.  Health Evaluation of Experimental Laboratory Mice.

Authors:  Tanya Burkholder; Charmaine Foltz; Eleanor Karlsson; C Garry Linton; Joanne M Smith
Journal:  Curr Protoc Mouse Biol       Date:  2012-06-01

4.  Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.

Authors:  Marieke E Hoonakker; Lisa M Verhagen; Elder Pupo; Alex de Haan; Bernard Metz; Coenraad F M Hendriksen; Wanda G H Han; Arjen Sloots
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

5.  Potency testing for a recombinant protein vaccine early in clinical development: Lessons from the Schistosoma mansoni Tetraspanin 2 vaccine.

Authors:  Guangzhao Li; Lara Hoeweler; Brian Keegan; Jin Peng; Larissa Scholte; Peter Hotez; Maria Elena Bottazzi; David Diemert; Jeffrey Bethony
Journal:  Vaccine X       Date:  2021-06-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.